NLRP3 and diabetes mellitus: Compared with the normal control group, the mRNA levels of NLRP3, NFE2L2, and NFKB1 in the diabetes model group were significantly increased, while they decreased in the SAL treatment group (P < 0.05), with the statistical difference.